Neuronetics (STIM) Research & Development (2017 - 2026)

Neuronetics (STIM) has 10 years of Research & Development data on file, last reported at $1.4 million in Q1 2026.

• Quarterly Research & Development fell 15.59% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 47.4% YoY) and the FY2025 annual result came in at $6.6 million, down 48.45% from the prior year.
• Research & Development fell to $1.4 million in Q1 2026 per STIM's latest filing, from $1.7 million in the prior quarter.
• Across five years, Research & Development topped out at $5.8 million in Q4 2024 and bottomed at $1.4 million in Q1 2026.
• The 5-year median for Research & Development is $2.2 million (2023), against an average of $2.3 million.
• The widest annual swing landed in 2024, when Research & Development soared 161.53%; it then sank 71.14% in 2025.
• Tracing STIM's Research & Development over 5 years: stood at $3.1 million in 2022, then declined by 29.69% to $2.2 million in 2023, then soared by 161.53% to $5.8 million in 2024, then slumped by 71.14% to $1.7 million in 2025, then retreated by 18.13% to $1.4 million in 2026.
• Per Business Quant, the three latest STIM Research & Development figures stand at $1.4 million (Q1 2026), $1.7 million (Q4 2025), and $1.5 million (Q3 2025).

Peer Comparison